论文部分内容阅读
近年来靶向药物在非小细胞肺癌二/三线治疗的研究很活跃,该文对该领域目前的研究现状以及相关的热点问题进行综述,主要侧重于临床常用的靶向药物。
In recent years, targeted drugs in the second / third line of non-small cell lung cancer research is very active, the current research in this area and the current hot issues are reviewed, the main focus of clinical commonly used targeted drugs.